Identification of distinct changes in gene expression after modulation of melanoma tumor antigen p97 (melanotransferrin) in multiple models in vitro and in vivo

Carcinogenesis

Volumn 28, Issue 10, 2007, Pages 2172-2183

  Suryo Rahmanto, Y ^a   Dunn, L L ^a   Richardson, D R ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; GLUTAMINASE; IRON BINDING PROTEIN; MYOCYTE ENHANCER FACTOR 2; PROTEIN P97; PROTEIN TYROSINE PHOSPHATASE; THIAMINE; THIAMINE TRIPHOSPHATASE; TRANSCRIPTION FACTOR; TRANSFERRIN; TUMOR ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CELL SURVIVAL; CELL TYPE; CONTROLLED STUDY; DOWN REGULATION; EXPERIMENTAL MODEL; FIBROBLAST; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE SILENCING; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MELANOMA; MELANOMA CELL; MEMBRANE TRANSPORT; MICROARRAY ANALYSIS; MOUSE; NEUROEPITHELIOMA; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SEQUENCE HOMOLOGY; UNINDEXED SEQUENCE; UPREGULATION;

ANIMALS; CELL DIVISION; CELL LINE, TUMOR; FIBROBLASTS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GENETIC VECTORS; HUMANS; MELANOMA; MICE; MICE, KNOCKOUT; NEOPLASM PROTEINS; NEUROECTODERMAL TUMORS, PRIMITIVE, PERIPHERAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFECTION;

EID: 34250201965     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgm096     Document Type: Article

References (46)

1. Woodbury,R.G. et al. (1980) Identification of a cell surface protein, p97, in human melanomas and certain other neoplasms. Proc Natl Acad. Sci. USA, 77, 2183-2187.
2. Brown,J.P. et al. (1981) Quantitative analysis of melanoma-associated antigen p97 in normal and neoplastic tissues. Proc. Nat Acad. Sci. USA, 78, 539-543.
3. Brown,J.P. et al. (1982) Human melanoma-associated antigen p97 is structurally and functionally related to transferrin. Nature, 296, 171-173.
4. Suryo Rahmanto,Y. et al. (2007) The melanoma tumor antigen, melano-transferrin (p97): A 25-year hallmark from iron metabolism to tumorigenesis. Oncogene. doi:10.1038/sj.onc.1210442.
5. Richardson,D.R. (2000) The role of the membrane-bound tumour antigen, melanotransferrin (p97), in iron uptake by the human malignant melanoma cell. Eur. J. Biochem.; 267, 1290-1298.
6. Sekyere,E.O. et al. (2005) Examination of the distribution of the transferrin homologue, melanotransferrin (tumour antigen p97), in mouse and human. Biochim. Biophys. Acta, 1722, 131-142.
7. Desrosiers,R.R. et al. (2003) Expression of melanotransferrin isoforms in human serum: Relevance to Alzheimer's disease. Biochem. J., 374, 463-471.
8. Rose,T.M. et al. (1986) Primary structure of the human melanoma-associated antigen p97 (melanotransferrin) deduced from the mRNA sequence. Proc. Natl Acad. Sci. USA, 83, 1261-1265.
9. Baker,E.N. et al. (1992) Human melanotransferrin (p97) has only one functional irbn-binding site. FEBS Lett., 298, 215-218.
10. Dunn,L.L. et al. (2006) The function of melanotransferrin: A role in melanoma cell proliferation and tumorigenesis. Carcinogenesis, 27, 2157-2169.
11. Sekyere,E.O. et al. (2006) Role of melanotransferrin in iron metabolism: Studies using targeted gene disruption in-vivo. Blood, 107, 2599-2601.
12. Richardson,D. et al. (1991) The uptake of inorganic iron complexes by human melanoma cells. Biochim. Biophys. Acta, 1093, 20-28.
13. Demeule,M. et al. (2002) High transcytosis of melanotransferrin (P97) across the blood-brain barrier. J. Neuruchem., 83, 924-933.
14. Jefferies,W.A. et al. (1996) Reactive microglia specifically associated with amyloid plaques in Alzheimer's disease brain tissue express melanotransferrin. Brain Res., 712, 122-126.
15. McNagny,K-M. et al. (1996) The eosinophil-specific cell surface antigen, EOS47, is a chicken homologue of the oncofetal antigen melanotransferrin. Blood, 87, 1343-1352.
16. Kawamoto,T. et al. (1998) Expression of membrane-bound transferrin-like protein p97 on the cell surface of chondrocytes. Eur. J. Biochem., 256, 503-509.
17. Sala,R. et al. (2002) The human melanoma associated protein melanotransferrin promotes endothelial cell migration and angiogenesis in vivo. Eur. J. Cell Biol., 81, 599-607.
18. Bertrand,Y. et al. (2007) Melanotransferrin induces human melanoma SK-Mel-28 cell invasion in vivo. Biochem. Biophys. Res. Commun., 353, 418-423.
19. Rolland,Y. et al. (2006) Melanotransferrin stimulates t-PA-dependent activation of plasminogen in endothelial cells leading to cell detachment. Biochim. Biophys. Acta, 1763, 393-401.
20. Demeule,M. et al. (2003) Regulation of plasminogen activation: A role for melanotransferrin (p97) in cell migration. Blood, 102 1723-1731.
21. Medina,M.A. et al. (1992) Relevance of glutamine metabolism to tumor cell growth. Mol. Cell. Biochem., 113, 1-15.
22. Aledo,J.C. et al. (1994) Phosphate-activated glutaminase expression during tumor development. FEBS Lett., 341, 39-42.
23. McKinsey,T.A. et al. (2002) MEF2: A calcium-dependent regulator of cell division, differentiation and death. Trends Biochem. Sci., 27, 40-47.
24. Zhao,M. et al. (1999) Regulation of the MEF2 family of transcription factors by p38. Mol. Cell. Biol., 19, 21-30.
25. Whitnall,M. et al. (2006) A class of iron chelators with a wide spectrum of potent antitumor activity that overcomes resistance to chemotherapeutics. Proc. Natl Acad. Sci. USA, 103, 14901-14906.
26. Gao,J. et al. (2001) The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents, IV: The mechanisms involved in inhibiting cell-cycle progression. Blood, 98, 842-850.
27. Bridge,A.J. et al. (2003) Induction of an interferon response by RNAi vectors in mammalian cells. Nat. Genet., 34, 263-264.
28. Estin,C.D. et al. (1989) Transfected mouse melanoma lines that express various levels of human melanoma-associated antigen p97. J. Natl Cancer Inst., 81, 445-448.
29. Ashburner,M. et al. (2000) Gene ontology: Tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet., 25, 25-29.
30. Graham,T.A. et al. (2001) Tcf4 can specifically recognize beta-catenin using alternative conformations. Nat. Struct. Biol., 8, 1048-1052.
31. Zhao,D.H. et al. (2004) Aberrant expression and function of TCF4 in the proliferation of hepatocellular carcinoma cell line BEL-7402. Cell Res., 14, 74-80.
32. Furumura,M. et al. (2001) Involvement of ITF2 in the transcriptional regulation of melanogenic genes. J. Biol. Chem., 276, 28147-28154.
33. Mann,B. et al. (1999) Target genes of beta-catenin-T cell-factor/ lymphoid-enhancer-factor signaling in human colorectal carcinomas. Proc. Natl Acad. Sci. USA, 96, 1603-1608.
34. Behrens,J. (2005) The role of the Wnt signalling pathway in colorectal tumorigenesis. Biochem. Soc. Trans., 33, 672-675.
35. Gordon,M.D. et al. (2006) Wnt signaling: Multiple pathways, multiple receptors, and multiple transcription factors. J. Biol. Chem., 281, 22429-22433.
36. Sato,A. et al. (2006) Profilin is an effector for Daam1 in non-canonical Wnt signaling and is required for vertebrate gastrulation. Development, 133, 4219-4231.
37. Makarchikov,A.F. et al. (2003) Thiamine triphosphate and thiamine triphosphatase activities: From bacteria to mammals. Cell. Mol. Life Sci., 60, 1477-1488.
38. Frank,N.Y. et al. (2003) Regulation of progenitor cell fusion by ABCB5 P-glycoprotein, a novel human ATP-binding cassette transporter. J. Biol. Chem., 278, 47156-47165.
39. Chen,K.G. et al. (2005) Principal expression of two mRNA isoforms (ABCB 5alpha and ABCB 5beta) of the ATP-binding cassette transporter gene ABCB 5 in melanoma cells and melanocytes. Pigment Cell Res., 18, 102-112.
40. Frank,N.Y. et al. (2005) ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma. Cancer Res., 65 4320-4333.
41. Tonks,N.K. (2006) Protein tyrosine phosphatases: From genes, to function, to disease. Nat. Rev. Mol. Cell Biol., 7, 833-846.
42. Easty,D. et al. (2006) Protein tyrosine phosphatases, new targets for cancer therapy. Curr. Cancer Drug Targets, 6, 519-532.
43. McArdle,L. et al. (2005) Microarray analysis of phosphatase gene expression in human melanoma. Br. J. Dermatol., 152, 925-930.
44. Souba,W.W. (1993) Glutamine and cancer. Ann. Surg., 218, 715-728.
45. Wang,Q. (2005) Advances in the genetic basis of coronary artery disease. Curr. Atheroscler. Rep., 7, 235-241.
46. Moreno,H. et al. (2003) Differential regulation of the muscle-specific GLUT4 enhancer in regenerating and adult skeletal muscle. J. Biol. Chem., 278, 40557-40564.